Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Increased serum phosphate concentration within the normal reference levels is associated with all-cause mortality in non-dialysis CKD patients: A five-year prospective cohort study Ana Cerqueira; Janete Quelhas-Santos; Núria Paulo; Claúdia Camila Dias; Manuel Pestana;

From stage 1 to end-stage renal failure: Amyloid ß42, amyloid ß40, amyloid ß42/40 ratio, p-tau181 and cognitive function relationship Yasemin Co¿kun Yavuz; Zeynep Biyik; Firdevs Sak; Muslu Kaz¿m Korez; Sedat Abusoglu; Lutfullah Altintepe;